Genaera Corporation
Records under this name other than the patents Genaera Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,981,876 | Polymorphic and amorphous salt forms of squalamine dilactate Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,716,270 | Polymorphic and amorphous salt forms of squalamine dilactate Formerly held Lapsed on the fee record Ended May 6, 2026 · USPTO record | Lapsed on the fee record | Ended May 6, 2026 | USPTO record |
| US 7,728,157 | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols Formerly held Lapsed on the fee record Ended Jun 1, 2022 · USPTO record | Lapsed on the fee record | Ended Jun 1, 2022 | USPTO record |
| US 7,074,778 | Asthma associated factors as targets for treating atopic allergies including asthma and related disorders Formerly held Term ended Term ended May 30, 2021 · USPTO record | Term ended | Term ended May 30, 2021 | USPTO record |
| US 6,933,383 | Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols Formerly held Term ended Term ended Apr 12, 2021 · USPTO record | Term ended | Term ended Apr 12, 2021 | USPTO record |
| US 7,410,959 | Therapeutic uses for aminosterol compounds Formerly held Lapsed on the fee record Ended Aug 12, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 12, 2020 | USPTO record |
| US 9,365,608 | Method for treating diabetes Formerly held Lapsed on the fee record Ended Jun 14, 2020 · USPTO record | Lapsed on the fee record | Ended Jun 14, 2020 | USPTO record |
| US 6,261,559 | Methods of treating asthma with interleukin-9 antibodies Term ended Term ended Jun 4, 2019 · USPTO record | Term ended | Term ended Jun 4, 2019 | USPTO record |
| US 7,056,698 | Nucleic acids encoding interleukin-9 receptor variants Term ended Term ended Nov 2, 2018 · USPTO record | Term ended | Term ended Nov 2, 2018 | USPTO record |
| US 6,610,866 | Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds Formerly held Term ended Term ended Mar 22, 2018 · USPTO record | Term ended | Term ended Mar 22, 2018 | USPTO record |